Jussemara Souza da Silva, Bruno Correia Ernandes, Carol Lee Luna Fernandes, Ademir Silva Correia, Cesar Cilento Ponce, Jaques Sztajnbok, Camila Rodrigues & José Ernesto Vidal. (2023) Septic shock, hyperferritinemic syndrome, and multiple organ dysfunction without respiratory failure in a patient with disseminated histoplasmosis and advanced HIV disease. Revista do Instituto de Medicina Tropical de São Paulo 65.
Crossref
Liliane Taverne-Ghadwal, Martin Kuhns, Timo Buhl, Marco H. Schulze, Weina Joseph Mbaitolum, Lydia Kersch, Michael Weig, Oliver Bader & Uwe Groß. (2022) Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era. Frontiers in Microbiology 13.
Crossref
Richard D. Cannon. (2022) Oral Fungal Infections: Past, Present, and Future. Frontiers in Oral Health 3.
Crossref
Darpan Bhargava, Rajkumar Ahirwal, Suyash Dubey, Preeti Gurjar, Ankit Pandey, Sivakumar Beena & Ganesh Koneru. (2021) COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent. Head and Neck Pathology 16:3, pages 645-650.
Crossref
Sweta Sharma & Arpita Yadav. (2020) Gingerol Derivatives as 14α-demethylase Inhibitors: Design and Development of Natural, Safe Antifungals for Immune-compromised Patients. Letters in Drug Design & Discovery 17:7, pages 918-928.
Crossref
Ruchi OmarArpita Yadav. (2017) A mechanistic study of anti-HIV activities of antifungal peptides. Canadian Journal of Chemistry 95:6, pages 633-640.
Crossref
Dennis Boumans, Gert-Jan Kootstra, Gerard H. van Olffen, Mariël Brinkhuis & Chris H.H. ten Napel. (2012) Adenovirus Esophagitis in an HIV-Positive Patient. Infectious Diseases in Clinical Practice 20:5, pages 354-356.
Crossref
María J. Núñez, Silvia Novío, Juan Antonio Suárez, José Balboa & Manuel Freire-Garabal. (2010) Effects of Psychological Stress and Fluoxetine on Development of Oral Candidiasis in Rats. Clinical and Vaccine Immunology 17:4, pages 668-673.
Crossref
Rakefet Czerninski, Sagi Sivan, Doron Steinberg, Irith Gati, Leonid Kagan & Michael Friedman. (2009) A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis. Clinical Oral Investigations 14:1, pages 71-78.
Crossref
I QUINTI, C PALMA, E C GUERRA, M J GOMEZ, I MEZZAROMA, F AIUTI & A CASSONE. (1991)
Proliferative and cytotoxic responses to mannoproteins of
Candida albicans
by peripheral blood lymphocytes of HIV-infected subjects
. Clinical and Experimental Immunology 85:3, pages 485-492.
Crossref
Irmgard Behlau. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
4717
4749
.
R. Giordani, P. Regli, J. Kaloustian, C. Mikaïl, L. Abou & H. Portugal. (2005)
Antifungal effect of various essential oils against
Candida
albicans
. Potentiation of antifungal action of amphotericin B by essential oil from
Thymus vulgaris
. Phytotherapy Research 18:12, pages 990-995.
Crossref
Flavia Bernardis, Evelina Tacconelli, Francesca Mondello, Adriana Cataldo, Silvia Arancia, Roberto Cauda & Antonio Cassone. (2004)
Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by
Candida albicans
without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility
. FEMS Immunology & Medical Microbiology 41:1, pages 27-34.
Crossref
Stephen L Foundling. 2004. Handbook of Proteolytic Enzymes. Handbook of Proteolytic Enzymes
115
119
.
Lynn Purkins, Nolan Wood, Katie Greenhalgh, Michael J. Allen & Stuart D. Oliver. (2003) Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety. British Journal of Clinical Pharmacology 56, pages 10-16.
Crossref
M. J. Núñez, J. Balboa, P. Riveiro, D. Liñares, P. Mañá, M. Rey-Méndez, A. Rodríguez-Cobos, J. A. Suárez-Quintanilla, L. A. García-Vallejo & M. Freire-Garabal. (2002) Effects of Psychological Stress and Alprazolam on Development of Oral Candidiasis in Rats. Clinical and Vaccine Immunology 9:4, pages 852-857.
Crossref
Kaaren G. Vargas & Sophie Joly. (2002) Carriage Frequency, Intensity of Carriage, and Strains of Oral Yeast Species Vary in the Progression to Oral Candidiasis in Human Immunodeficiency Virus-Positive Individuals. Journal of Clinical Microbiology 40:2, pages 341-350.
Crossref
M. Kretschmar, S. Amselem, E. Zawoznik, K. Mosbach, A. Dietz, H. Hof & T. Nichterlein. (2001)
Efficient treatment of murine systemic infection with
Candida albicans
using amphotericin B incorporated in nanosize range particles (emulsomes)
. Mycoses 44:7-8, pages 281-286.
Crossref
Jose A. Vazquez, Grace Peng, Jack D. Sobel, Lynn Steele‐Moore, Paula Schuman, William Holloway & James D. Neaton. (2001)
Evolution of Antifungal Susceptibility among
Candida
Species Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
. Clinical Infectious Diseases 33:7, pages 1069-1075.
Crossref
M A John & Y M Coovadia. (2016) Shortfalls in the Use of Adenosine Deaminase in Tuberculous Meningitis. Tropical Doctor 31:3, pages 138-139.
Crossref
Ma Muñoz‐Pèrez, A Rodriguez‐Pichardo, F Camacho & Jj Ríos. (2003)
Extensive and deep dermatophytosis caused by
Trichophyton mentagrophytes var. Interdigitalis
in an HIV‐1 positive patient
. Journal of the European Academy of Dermatology and Venereology 14:1, pages 61-63.
Crossref
Marianne Kretschmar, Bernhard Hube, Thomas BertschDominique Sanglard, Renate Merker, Meike Schröder, Herbert Hof & Thomas Nichterlein. (1999)
Germ Tubes and Proteinase Activity Contribute to Virulence of
Candida albicans
in Murine Peritonitis
. Infection and Immunity 67:12, pages 6637-6642.
Crossref
M. Freire-Garabal, M. J. Núñez, J. Balboa, A. Rodríguez-Cobo, J. M. López-Paz, M. Rey-Méndez, J. A. Suárez-Quintanilla, J. C. Millán & J. M. Mayán. (1999) Effects of Amphetamine on Development of Oral Candidiasis in Rats. Clinical Diagnostic Laboratory Immunology 6:4, pages 530-533.
Crossref
F. de Bernardis, F. Mondello, G. Scaravelli, A. Pachì, A. Girolamo, L. Agatensi & A. Cassone. (1999) High Aspartyl Proteinase Production and Vaginitis in Human Immunodeficiency Virus-Infected Women. Journal of Clinical Microbiology 37:5, pages 1376-1380.
Crossref
C?lia Regina GARLIPP, Cl?udio L?cio ROSSI & Paula Virginia BOTTINI. (1997) Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis. Revista do Instituto de Medicina Tropical de S?o Paulo 39:6, pages 323-326.
Crossref
Faith M. Durden & Boni Elewski. (1997) Fungal infections in HIV-infected patients. Seminars in Cutaneous Medicine and Surgery 16:3, pages 200-212.
Crossref
D Coleman, D Sullivan, B Harrington, K Haynes, M Henman, D Shanley, D Bennett, G Moran, C McCreary & L O'Neill. (2013)
Molecular and phenotypic analysis of
Candida dubliniensis
: A recently identified species linked with oral candidosis in HIV‐infected and AIDS patients
. Oral Diseases 3:S1.
Crossref
Frank Sorvillo, Gildon Beall, Paul A. Turner, Victor L. Beer, Andrea A. Kovacs & Peter R. Kerndt. (1997) Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County. AIDS 11:5, pages 673-679.
Crossref
David C. Coleman, Derek J. Sullivan, Désirée E. Bennett, Gary P. Moran, Hugh J. Barry & Diarmuid B. Shanley. (1997) Candidiasis. AIDS 11:5, pages 557-567.
Crossref
M. Kretschmar, C. Jung, E. Fontagnier, B. Quade, T. Nichterlein & H. Hof. (1997)
Activated CD3
+
T cells are involved in elimination of
Candida albicans
from the livers of mice
. Mycoses 40:1-2, pages 41-46.
Crossref
Irina Bournerias, Martine Feuilhade De Chauvin, Annick Datry, Isabelle Chambrette, Jean Carriere, Alain Devidas & François Blanc. (1996) Unusual Microsporum canis infections in adult HIV patients. Journal of the American Academy of Dermatology 35:5, pages 808-810.
Crossref
Caroline S. Zeind, Kerry O. Cleveland, Madhavi Menon, James R. Brown & David K. Solomon. (2012) Cryptococcal Meningitis in Patients with the Acquired Immunodeficiency Syndrome. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16:4, pages 547-561.
Crossref
J.J. Sciubba. (2016) Opportunistic Oral Infections in the Immunosuppressed Patient: Oral Hairy Leukoplakia and Oral Candidiasis. Advances in Dental Research 10:1, pages 69-72.
Crossref
Z.K. Khan, Ratna Katiyar, R. Shukla, R. Kulshreshtha & Asha Mathur. (1996) Cryptococcosis Associated with HIV Negative Indian Patients and HIV Positive Indian Blood Donors. Zentralblatt für Bakteriologie 283:3, pages 360-374.
Crossref
F De Bernardis, P Chiani, M Ciccozzi, G Pellegrini, T Ceddia, G D'Offizzi, I Quinti, P A Sullivan & A Cassone. (1996) Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.. Infection and immunity 64:2, pages 466-471.
Crossref
R J Coker, M Fisher & D R Tomlinson. (2016) Management of Mycoses Associated with HIV Disease. International Journal of STD & AIDS 6:6, pages 408-412.
Crossref
A LupettiG GuzziA PaladiniK SwartM CampaS Senesi. (1995) Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. Journal of Clinical Microbiology 33:5, pages 1238-1242.
Crossref
F De BernardisA CassoneJ SturtevantR Calderone. (1995) Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infection and Immunity 63:5, pages 1887-1892.
Crossref
P. Diz Dios, J. Alvarez Alvarez, J. Fernández Feijoo & M. Castro Ferreiro. (1995) Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 79:2, pages 170-174.
Crossref
J.A. Fishman & A.R. Mattia. (1995) Case 3-1995. New England Journal of Medicine 332:4, pages 249-257.
Crossref
Martin Fusek, Elizabeth Smith & Stephen I. Foundling. 1995. Aspartic Proteinases. Aspartic Proteinases
489
500
.
DAVID A. BAKER. (1994) Management of the Female HIV-infected Patient. AIDS Research and Human Retroviruses 10:8, pages 935-938.
Crossref
A. Kolokotronis, V. Kioses, D. Antoniades, K. Mandraveli, I. Doutsos & P. Papanayotou. (1994) Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology 78:1, pages 41-46.
Crossref
Jo?o Baptista dos Reis-Filho, Sandro Luiz Andrade Matas, Olga Fischman, Belinda Calvo Morales & Yara Juliano. (1994) Estudo comparativo do LCR de pacientes com neurocriptococose sem AIDS e com AIDS. Revista do Instituto de Medicina Tropical de S?o Paulo 36:3, pages 225-230.
Crossref
Paul L. FidelJr.Jr. & Jack D. Sobel. (1994) The role of cell-mediated immunity in candidiasis. Trends in Microbiology 2:6, pages 202-206.
Crossref
C. Scully, M. EI-Kabir & Lakshman P. Samaranayake. (2016) Candida and Oral Candidosis: A Review. Critical Reviews in Oral Biology & Medicine 5:2, pages 125-157.
Crossref
C L Daley. (1994) Tropical respiratory medicine. 1. Pulmonary infections in the tropics: impact of HIV infection.. Thorax 49:4, pages 370-378.
Crossref
J. Chakir, L. Côté, C. Coulombe & N. Deslauriers. (2007)
Differential pattern of infection and i immune response during experimental oral candidiasis in BALB/c and DBA/2 (H‐2
d
) mice
. Oral Microbiology and Immunology 9:2, pages 88-94.
Crossref
G. B. Gaeta, A. Maisto, C. Sichenze, C. Sardaro, G. Giusti & R. A. Satriano. (1994) Mucocutaneous diseases in drug addicts with or without HIV infection. A case-control studyMukokutane Krankheiten bei Drogenabhängigen mit oder ohne HIV-Infektion. Fall-Kontroll-Studie. Infection 22:2, pages 77-80.
Crossref
V JolyR FarinottiL Saint-JulienM ChéronC CarbonP Yeni. (1994) In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid. Antimicrobial Agents and Chemotherapy 38:2, pages 177-183.
Crossref
L. R. Eversole, J. Fleischmann, G. C. Baldwin & J. P. Sapp. (2007) The effects of human immunodeficiency virus infection on macrophage phagocytosis of Candida. Oral Microbiology and Immunology 9:1, pages 55-59.
Crossref
David J. Zegarelli. (1993) Fungal Infections Of The Oral Cavity. Otolaryngologic Clinics of North America 26:6, pages 1069-1089.
Crossref
D SullivanD BennettM HenmanP HarwoodS FlintF MulcahyD ShanleyD Coleman. (1993) Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. Journal of Clinical Microbiology 31:8, pages 2124-2133.
Crossref
T G SieckM A MoorsH R BuckleyK J Blank. (1993) Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infection and Immunity 61:8, pages 3540-3543.
Crossref
Vassil St. Georgiev. (2006) Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis. Medicinal Research Reviews 13:4, pages 493-506.
Crossref
Marcos Boulos. (1993) Tratamento pelo fluconazol de pacientes imuno-comprometidos com graves infec??es f?ngicas. Revista do Instituto de Medicina Tropical de S?o Paulo 35:1, pages 81-87.
Crossref
Mark Zervos & Françoise Meunier. (1993) Fluconazole (Diflucan®): a review. International Journal of Antimicrobial Agents 3:3, pages 147-170.
Crossref
A Espinel-IngroffC W KishJrJrT M KerkeringR A FromtlingK BartizalJ N GalgianiK VillarealM A PfallerT GerardenM G Rinaldi. (1992) Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 30:12, pages 3138-3145.
Crossref
M�nica Lowinger-Seoane, Josep M. Torres-Rodr�guez, Neus Madrenys-Brunet, Salvador Aregall-Fust� & Pere Saballs. (1992) Extensive dermatophytoses caused by Trichophyton mentagrophytes and Microsporum canis in a patient with AIDS. Mycopathologia 120:3, pages 143-146.
Crossref
Massimo Bruatto, Valerio Vidotto & Anna Maria Maina. (1992) Growth of Cryptococcus neoformans in a thiamine-free medium. Mycopathologia 119:3, pages 129-132.
Crossref
F. de Bernardis, M. Boccanera, L. Rainaldi, C. E. Guerra, I. Quinti & A. Cassone. (1992) The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. European Journal of Epidemiology 8:3, pages 362-367.
Crossref
Crispian Scully & Gillian McCarthy. (1992) Management of oral health in persons with HIV infection. Oral Surgery, Oral Medicine, Oral Pathology 73:2, pages 215-225.
Crossref
Gillian M. McCarthy. (1992) Host factors associated with HIV-related oral candidiasis. Oral Surgery, Oral Medicine, Oral Pathology 73:2, pages 181-186.
Crossref
L. Zamora & J.M. Gatell. (1992) Infecciones pulmonares en los pacientes con síndrome de inmunodeficiencia adquirida. Archivos de Bronconeumología 28:1, pages 32-38.
Crossref
Claude P. Selitrennikoff. 1992. Biotechnology of Filamentous Fungi. Biotechnology of Filamentous Fungi
189
217
.
Joan Elizabeth Kapusnik-Uner. 1992. Applied Therapeutics. Applied Therapeutics
859
887
.
Gillian M. McCarthy, Iain D. Mackie, John Koval, Harinder S. Sandhu & Thomas D. Daley. (2006) Factors associated with increased frequency of HIV‐related oral candidiasis. Journal of Oral Pathology & Medicine 20:7, pages 332-336.
Crossref
D L Brawner. (1991) Comparison between methods for serotyping of Candida albicans produces discrepancies in results. Journal of Clinical Microbiology 29:5, pages 1020-1025.
Crossref
J M ClarkR R WhitneyS J OlsenR J GeorgeM R SwerdelL KunselmanD P Bonner. (1991) Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrobial Agents and Chemotherapy 35:4, pages 615-621.
Crossref
S. G. LIM, C. A. LEE, M. HALES, M. O'DOHERTY, M. WINTER & P. B. A. KERNOFF. (2007) Fluconazole for oropharyngeal candidiasis in anti‐HIV positive haemophiliacs. Alimentary Pharmacology & Therapeutics 5:2, pages 199-205.
Crossref
Frank M. Lucatorto, Colin Franker, W. David Hardy & Suzette Chafey. (1991) Treatment of refractory oral candidiasis with fluconazole. Oral Surgery, Oral Medicine, Oral Pathology 71:1, pages 42-44.
Crossref
G. Morace, E. Tamburrini, S. Manzara, A. Antinori, G. Maiuro & G. Dettori. (1990) Epidemiological and clinical aspects of mycoses in patients with aids-related pathologies. European Journal of Epidemiology 6:4, pages 398-403.
Crossref
C. Farina, F. Castelli & G. Carosi. (1990) Epidemiology of digestive tract mycoses in immunocompromised patients ? A review. European Journal of Epidemiology 6:4, pages 363-370.
Crossref
Gudrun Just-Nübling, Gabriele Gentschew, Monika Döhle, C. Böttinger, Eilke-Brigitte Helm & W. Stille. (1990) Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients. Mycoses 33:9-10, pages 435-440.
Crossref
Philip R. Cohen, David E. Bank, David N. Silvers & Marc E. Grossman. (1990) Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. Journal of the American Academy of Dermatology 23:3, pages 422-428.
Crossref
Colin K. Franker, Frank M. Lucartorto, Barton S. Johnson & Jed J. Jacobson. (1990) Characterization of the mycoflora from oral mucosal surfaces of some HIV-infected patients. Oral Surgery, Oral Medicine, Oral Pathology 69:6, pages 683-687.
Crossref
J. N. Cox, F. Dió, G. -P. Pizzolato, R. Lerch & N. Pochon. (1990) Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). Virchows Archiv A Pathological Anatomy and Histopathology 417:3, pages 255-259.
Crossref
Bertrand Dupont. 1990. Chemotherapy of Fungal Diseases. Chemotherapy of Fungal Diseases
421
437
.
Hans Christian Korting. 1990. Vorträge der XII. Fortbildungswoche der Dermatologischen Klinik und Poliklinik der Ludwig-Maximilians-Universität München in Verbindung mit dem Berufsverband der Deutschen Dermatologen e.V. vom 23. bis 28. Juli 1989. Vorträge der XII. Fortbildungswoche der Dermatologischen Klinik und Poliklinik der Ludwig-Maximilians-Universität München in Verbindung mit dem Berufsverband der Deutschen Dermatologen e.V. vom 23. bis 28. Juli 1989
239
248
.
Edouard Drouhet & Bertrand Dupont. 1990. Mycoses in AIDS Patients. Mycoses in AIDS Patients
27
53
.
G. Just, D. Steinheimer, M. Schnellbach, C. Böttinger, E. B. Helm & W. Stille. 1990. Mycoses in AIDS Patients. Mycoses in AIDS Patients
279
285
.
H. C. Korting. 1990. Mycoses in AIDS Patients. Mycoses in AIDS Patients
255
264
.
Maria Anna Viviani & Anna Maria Tortorano. 1990. Mycoses in AIDS Patients. Mycoses in AIDS Patients
147
153
.
Francis W. Chandler. 1990. Mycoses in AIDS Patients. Mycoses in AIDS Patients
3
12
.
G. Just, D. Steinheimer, M. Schnellbach, C. Böttinger, E.B. Helm & W. Stille. (2009) Change of Causative Organisms under Antifungal Treatment in Immunosuppressed Patients with HIV-Infections. Mycoses 32, pages 47-51.
Crossref
H.C. Korting. (2009) Clinical Spectrum of Oral Candidosis and its Role in HIV-Infected Patients. Mycoses 32, pages 23-29.
Crossref
David K. Stein & Alan M. Sugar. (1989) Fungal infections in the immunocompromised host. Diagnostic Microbiology and Infectious Disease 12:4, pages 221-228.
Crossref
S. De Wit & N. Clumeck. (1989) Fluconazole in the treatment of fungal infections associated with AIDS. Infection 17:3, pages 121-123.
Crossref
Rog?rio de Jesus Pedro, Francisco Hideo Aoki, Raquel Silveira Bello Stucchi Boccato, Maria Luiza Moretti Branchini, Fernando Lopes Gon?ales J?nior, Priscila Maria de Oliveira Papaiordanou & Marcelo de Carvalho Ramos. (1989) Paracoccidioidomicose e infec??o pelo virus da imunodefici?ncia humana. Revista do Instituto de Medicina Tropical de S?o Paulo 31:2, pages 119-125.
Crossref
L. Z. Goldani, R. Martinez, G. A. M. Landell, A. A. Machado & V. Coutinho. (1989) Paracoccidioidomycosis in a patient with acquired immunodeficiency syndrome. Mycopathologia 105:2, pages 71-74.
Crossref
M W Krause & A Schaffner. (1989) Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions.. Infection and Immunity 57:11, pages 3472-3478.
Crossref
Stephen M. Strigle & Anthony A. Gal. (2006) A review of pulmonary cytopathology in the acquired immunodeficiency syndrome. Diagnostic Cytopathology 5:1, pages 44-54.
Crossref
H C KortingM OllertA GeorgiiM Fröschl. (1988) In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. Journal of Clinical Microbiology 26:12, pages 2626-2631.
Crossref
Paul A. Levine, Sukgi S. Choi, William Lawson, Edward J. Bottone & Hugh F. Biller Md. (1988) Cryptococcal Sinusitis: A Case Report and Review of Literature. Otolaryngology–Head and Neck Surgery 99:4, pages 414-418.
Crossref
Steven Z. Glickel. (1988) Hand infections in patients with acquired immunodeficiency syndrome. The Journal of Hand Surgery 13:5, pages 770-775.
Crossref
Frank Paul ScalfanoJr.Jr., John G. Prichard, Neela Lamki, Patricia Ann Athey & Richard C. Graves. (1988) Abdominal cryptococcoma in aids: A case report. Journal of Computed Tomography 12:3, pages 237-239.
Crossref
George Foulds, Doreen R. Brennan, Charles Wajszczuk, Antonino Catanzaro, Dyal C. Garg, William Knopf, Michael Rinaldi & Donald J. Weidler. (2013) Fluconazole Penetration into Cerebrospinal Fluid in Humans. The Journal of Clinical Pharmacology 28:4, pages 363-366.
Crossref
H. J. Stutte & S. Falk. 1988. AIDS und Lunge. AIDS und Lunge
29
44
.
Michael R. Cairns. (1988) Fungal infections in the acquired immunodeficiency syndrome. Journal of Electron Microscopy Technique 8:1, pages 115-131.
Crossref
Anthony A. Gal, Susan Evans & Paul R. Meyer. (1987) The clinical laboratory evaluation of cryptococcal infections in the acquired immunodeficiency syndrome. Diagnostic Microbiology and Infectious Disease 7:4, pages 249-254.
Crossref